Publication | Open Access

Juvenile treatment with a novel mGluR2 agonist/mGluR3 antagonist compound, LY395756, reverses learning deficits and cognitive flexibility impairments in adults in a neurodevelopmental model of schizophrenia

Neuropsychological FunctioningJuvenile TreatmentCognitive Flexibility ImpairmentsPsychiatryDevelopmental Cognitive NeurosciencePsychotic DisorderNeurodevelopmental ModelSchizophreniaNeuropsychiatrySocial SciencesRehabilitationNeuroscienceBiological PsychiatryMedicinePsychopathology